300550 Stock Overview
Heren Health Co., Ltd. provides medical solutions to hospitals and governments in China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Heren Health Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥9.35 |
52 Week High | CN¥18.55 |
52 Week Low | CN¥7.03 |
Beta | 0.41 |
1 Month Change | -25.91% |
3 Month Change | -23.30% |
1 Year Change | -46.48% |
3 Year Change | -22.13% |
5 Year Change | -61.01% |
Change since IPO | 42.22% |
Recent News & Updates
Recent updates
Shareholder Returns
300550 | CN Healthcare Services | CN Market | |
---|---|---|---|
7D | -8.2% | -8.0% | -0.4% |
1Y | -46.5% | -48.1% | -16.2% |
Return vs Industry: 300550 exceeded the CN Healthcare Services industry which returned -48.1% over the past year.
Return vs Market: 300550 underperformed the CN Market which returned -16.2% over the past year.
Price Volatility
300550 volatility | |
---|---|
300550 Average Weekly Movement | 13.2% |
Healthcare Services Industry Average Movement | 11.3% |
Market Average Movement | 8.9% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 300550's share price has been volatile over the past 3 months.
Volatility Over Time: 300550's weekly volatility has increased from 8% to 13% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 806 | Chenhui Zhao | www.herenit.com |
Heren Health Co., Ltd. provides medical solutions to hospitals and governments in China. It offers hospital clinical informatization, hospital clinical data scenarioizing, urban smart medical cloud platform, medical community platform, etc. The company was founded in 2010 and is headquartered in Hangzhou, China.
Heren Health Co., Ltd. Fundamentals Summary
300550 fundamental statistics | |
---|---|
Market cap | CN¥2.46b |
Earnings (TTM) | -CN¥94.98m |
Revenue (TTM) | CN¥339.86m |
7.2x
P/S Ratio-25.8x
P/E RatioIs 300550 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300550 income statement (TTM) | |
---|---|
Revenue | CN¥339.86m |
Cost of Revenue | CN¥296.45m |
Gross Profit | CN¥43.41m |
Other Expenses | CN¥138.39m |
Earnings | -CN¥94.98m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 25, 2024
Earnings per share (EPS) | -0.36 |
Gross Margin | 12.77% |
Net Profit Margin | -27.95% |
Debt/Equity Ratio | 10.4% |
How did 300550 perform over the long term?
See historical performance and comparison